Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

被引：0
作者：
H. Low
A. Hoang
J. Forbes
M. Thomas
J. G. Lyons
P. Nestel
L. A. Bach
D. Sviridov
机构：
[1] Baker Heart and Diabetes Institute,Department of Medicine
[2] Monash University,Department of Endocrinology and Diabetes
[3] Alfred Hospital,Department of Biochemistry and Molecular Biology
[4] Monash University,undefined
来源：
Diabetologia | 2012年 / 55卷
关键词：
AGE; Cholesterol; Diabetes; HDL; Reverse cholesterol transport;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2513 / 2521
页数：8
相关论文
共 50 条
  • [21] Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes
    Karim, Lamya
    Moulton, Julia
    Van Vliet, Miranda
    Velie, Kelsey
    Robbins, Ann
    Malekipour, Fatemeh
    Abdeen, Ayesha
    Ayres, Douglas
    Bouxsein, Mary L.
    BONE, 2018, 114 : 32 - 39
  • [22] Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength
    Leanza, Giulia
    Cannata, Francesca
    Faraj, Malak
    Pedone, Claudio
    Viola, Viola
    Tramontana, Flavia
    Pellegrini, Niccolo
    Vadala, Gianluca
    Piccoli, Alessandra
    Strollo, Rocky
    Zalfa, Francesca
    Beeve, Alec T.
    Scheller, Erica L.
    Tang, Simon Y.
    Civitelli, Roberto
    Maccarrone, Mauro
    Papalia, Rocco
    Napoli, Nicola
    ELIFE, 2024, 12
  • [23] ADVANCED GLYCATION END-PRODUCTS (AGES) INDUCE GLOMERULAR SCLEROSIS AND ALBUMINURIA IN NORMAL RATS
    VLASSARA, H
    STRIKER, LJ
    TEICHBERG, S
    FUH, H
    LI, YM
    STEFFES, M
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1995, 7 (33) : 69 - 71
  • [24] Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications
    Yan, Shi Fang
    Ramasamy, Ravichandran
    Schmidt, Ann Marie
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (05): : 285 - 293
  • [25] Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
    Asadipooya, Kamyar
    Uy, Edilfavia Mae
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (10) : 1799 - 1818
  • [26] Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients
    Takeda, Munehiro
    Ojima, Miki
    Yoshioka, Hideo
    Inaba, Hiroaki
    Kogo, Mikihiko
    Shizukuishi, Satoshi
    Nomura, Makoto
    Amano, Atsuo
    JOURNAL OF PERIODONTOLOGY, 2006, 77 (01) : 15 - 20
  • [27] Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes
    Aubert, C. E.
    Michel, P. -L.
    Gillery, P.
    Jaisson, S.
    Fonfrede, M.
    Morel, F.
    Hartemann, A.
    Bourron, O.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 679 - 685
  • [28] Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification
    Cavati, Guido
    Pirrotta, Filippo
    Merlotti, Daniela
    Ceccarelli, Elena
    Calabrese, Marco
    Gennari, Luigi
    Mingiano, Christian
    ANTIOXIDANTS, 2023, 12 (04)
  • [29] Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
    Chiu, Chung-Jung
    Rabbani, Naila
    Rowan, Sheldon
    Chang, Min-Lee
    Sawyer, Sherilyn
    Hu, Frank B.
    Willett, Walter
    Thornalley, Paul J.
    Anwar, Attia
    Bar, Liliana
    Kang, Jae H.
    Taylor, Allen
    BIOFACTORS, 2018, 44 (03) : 281 - 288
  • [30] Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study
    Alkhami, Fadi
    Borderie, Gauthier
    Foussard, Ninon
    Larroumet, Alice
    Blanco, Laurence
    Barbet-Massin, Marie-Amelie
    Ferriere, Amandine
    Ducos, Claire
    Mohammedi, Kamel
    Fawaz, Sami
    Couffinhal, Thierry
    Rigalleau, Vincent
    DIABETES & METABOLISM, 2024, 50 (02)
12345